Showing results (1-10 of 216) with videos related to

Sort By:
Pageof 22
Experimental Dermatology|April 13, 2024
Symptomatic brain metastases in melanomaAndrea Knox, Tim Wang, Mark Shackleton, et al.
Clinical & Experimental Ophthalmology|September 24, 2025
Systemic Surveillance Guidelines for Uveal Melanoma: A Systematic ReviewFarzana Y Zaman, Aisha Ghaus, Mark Shackleton, et al.
Ophthalmology. Retina|October 18, 2023
Globe Salvage and Vision Preservation by Neoadjuvant Darovasertib and Crizotinib in Uveal MelanomaAlison Hiong, Roderick O'Day, Lotte S Fog, et al.
Journal of Clinical Pharmacy and Therapeutics|January 28, 2020
Combination of BRAF and MEK inhibition in BRAF V600E mutant low-grade gangliogliomaWing Hing Yau, Malaka Ameratunga
Expert Opinion on Biological Therapy|March 25, 2014
Bevacizumab for the treatment of high-grade glioma: an update after phase III trialsMustafa Khasraw, Malaka Ameratunga, Christian Grommes
Clinical Medicine Insights. Oncology|March 8, 2018
Development of Molecularly Targeted Agents and Immunotherapies in Glioblastoma: A Personalized ApproachNiamh Coleman, Malaka Ameratunga, Juanita Lopez
Pigment Cell & Melanoma Research|June 30, 2025
Prospective Isolation According to Melanin Pigment Content of Melanoma Cells With Heterogeneous Potentials for Disease PropagationClare Fedele, Gamze Kuser-Abali, Ralph Rossi, et al.
Journal of Clinical Pharmacy and Therapeutics|January 12, 2022
Dramatic clinical response in the treatment of small cell glioblastoma multiformeFarzana Yasmin Zaman, Catriona McLean, Malaka Ameratunga
Clinical and Translational Medicine|April 17, 2024
Computational repurposing of oncology drugs through off-target drug binding interactions from pharmacological databasesImogen R Walpole, Farzana Y Zaman, Peinan Zhao, et al.
Clinical & Experimental Ophthalmology|February 3, 2026
Uveal Melanoma Treatment: An UpdateAlison Hiong, Darvy Dang, Malaka Ameratunga, et al.
Pageof 22